References
- Kodaira T, Tomita N, Tachibana H, Nakamura T, Nakahara R, Inokuchi H, et al. Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy. Int J Radiat Oncol Biol Phys 2009; 73: 1129-34. 10.1016/j.ijrobp.2008.06.1936
- Chen AM, Jennelle RLS, Sreeraman R, Yang CC, Liu T, Vijayakumar S, et al. Initial clinical experience with helical tomotherapy for head and neck cancer. Head Neck 2009; 31: 1571-8. 10.1002/hed.21123
- Ren G, Du L, Ma L, Feng L-C, Zhou G-X, Qu B-L, et al. Clinical observation of 73 nasopharyngeal carcinoma patients treated by helical tomotherapy: the China experience. Technol Cancer Res Treat 2011; 10: 259-66. 10.7785/tcrt.2012.500201
- Van Gestel D, van Vliet-Vroegindeweij C, Van den Heuvel F, Crijns W, Coelmont A, De Ost B, et al. RapidArc, SmartArc and TomoHD compared with classical step and shoot and sliding window intensity modulated radiotherapy in an oropharyngeal cancer treatment plan comparison. Radiat Oncol 2013; 8: 37. 10.1186/1748-717X-8-37
- Broggi S, Perna L, Bonsignore F, Rinaldin G, Fiorino C, Chiara A, et al. Static and rotational intensity modulated techniques for head-neck cancer radiotherapy: a planning comparison. Phys Med 2014; 30: 973-9. 10.1016/j.ejmp.2014.07.001
- AJCC cancer staging manual. 7th edition. Philadelphia: Lippincott-Raven; 2009.
- Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009; 27: 3684-90. 10.1200/JCO.2008.19.9109
- US National Institute of Health. Cancer Therapy Evaluation Program. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). [citated 2017 Aug 9]. Available at program https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/ctcaev3.pdf
- Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6. 10.1016/0360-3016(95)00060-C
- Nutting C, Dearnaley DP, Webb S. Intensity modulated radiation therapy: a clinical review. Br J Radiol 2000; 73: 459-69.
- Eisbruch A, Ship JA, Martel MK, Ten Haken RK, Marsh LH, Wolf GT, et al. Parotid gland sparing in patients undergoing bilateral head and neck irradiation: techniques and early results. Int J Radiat Oncol Biol Phys 1996; 36: 469-80. 10.1259/bjr.73.869.10884741
- Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999; 45: 577-87.
- Kreps S, Berges O, Belin L, Zefkili S, Petras S, Giraud P. Salivary gland-sparing helical tomotherapy for head and neck cancer: Preserved salivary function on quantitative salivary gland scintigraphy after tomotherapy. Eur Ann Otorhinolaryngol Head Neck Dis 2016; 133: 257-62. 10.1016/j.anorl.2016.05.003
- Voordeckers M, Farrag A, Everaert H, Tournel K, Storme G, Verellen D, et al. Parotid gland sparing with helical tomotherapy in head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012; 84: 443-8. 10.1016/j.ijrobp.2011.11.070
- Jiang F, Jin T, Feng X-L, Jin Q-F, Chen X-Z. Long-term outcomes and failure patterns of patients with nasopharyngeal carcinoma staged by magnetic resonance imaging in intensity-modulated radiotherapy era: The Zhejiang Cancer Hospital’s experience. J Cancer Res Ther 2015; 11(Suppl 2): C179-84. 10.4103/0973-1482.168181
- Pow EH, Kwong DL, McMillan AS et al. Xerostomia and quality of life after intensity-modulated radiotherapy versus conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006; 66: 981–991.
- Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol. 2007 Nov 1; 25(31): 4873-9.
- Nutting C, Morden J, Harrington K et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011; 12: 127-136.
- Gupta T, Agarwal J, Jain S et al. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: A randomized controlled trial. Radiother Oncol. 2012; 104: 343-348.
- Peng G, Wang T, Yang KY et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012; 104: 286-293.
- Leung SW, Lee T-F. Treatment of nasopharyngeal carcinoma by tomotherapy: five-year experience. Radiat Oncol 2013; 8: 107. 10.1186/1748-717X-8-107
- Du L, Zhang X-X, Ma L, Feng L-C, Li F, Zhou G-X, et al. Clinical study of nasopharyngeal carcinoma treated by helical tomotherapy in China: 5-year outcomes. Biomed Res Int 2014; e980767. 10.1155/2014/980767
- Du L, Zhang XX, Feng LC, Chen J, Yang J, Liu HX, et al. Treatment of nasopharyngeal carcinoma using simultaneous modulated accelerated radiation therapy via helical tomotherapy: a phase II study. Radiol Oncol 2016; 50: 218-25. 10.1515/raon-2016-0001
- Wong FCS, Ng AWY, Lee VHF, Lui CMM, Yuen K-K, Sze W-K, et al. Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2010; 76: 138-45. 10.1016/j.ijrobp.2009.01.084
- Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys 2006; 64: 57-62. 10.1016/j.ijrobp.2005.03.057
- Kam MKM, Teo PML, Chau RMC, Cheung KY, Choi PHK, Kwan WH, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2004; 60: 1440-50. 10.1016/j.ijrobp.2004.05.022
- Tham IW-K, Hee SW, Yeo RM-C, Salleh PB, Lee J, Tan TW-K, et al. Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience. Int J Radiat Oncol Biol Phys 2009; 75: 1481-6. 10.1016/j.ijrobp.2009.01.018
- Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 2002; 53: 12-22.
- Liu W-S, Su M-C, Wu M-F, Tseng H-C, Kuo H-C. Nasopharyngeal carcinoma treated with precision-oriented radiation therapy techniques including intensity-modulated radiotherapy: preliminary results. Kaohsiung J Med Sci 2004; 20: 49-55. 10.1016/S1607-551X(09)70084-1
- Wang R, Wu F, Lu H, Wei B, Feng G, Li G, et al. Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study. J Cancer Res Clin Oncol 2013; 139: 139-45. 10.1007/s00432-012-1313-0
- Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, et al. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys 2000; 48: 711-22.
- Zhang X, Du L, Zhao F, Wang Q, Yang S, Ma L. A Phase II clinical trial of concurrent helical tomotherapy plus cetuximab followed by adjuvant chemotherapy with cisplatin and docetaxel for locally advanced nasopharyngeal carcinoma. Int J Biol Sci 2016; 12: 446-53. 10.7150/ijbs.12937
- Yao W, Du L, Ma L, Feng L, Cai B, Xu S, et al. Effect of adaptive replanning on adverse reactions and clinical outcome in nasopharyngeal carcinoma treated by helical tomotherapy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2013; 38: 468-75. 10.3969/j.issn.1672-7347.2013.05.005